AEHR Test Systems buy krebskrebs
Start price
19.04.21
/
50%
€1.71
Target price
19.04.22
€2.20
Performance (%)
382.40%
End price
20.04.22
€8.25
Summary
This prediction ended on 20.04.22 with a price of €8.25. With a performance of 382.40% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
AEHR Test Systems | 4.127% | 4.127% | -51.652% | - |
iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
Comments by krebskrebs for this prediction
In the thread Aehr Test Systems diskutieren
Buy mit Kursziel 2,2
In the thread Trading Aehr Test Systems
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten